Cite
HARVARD Citation
Paul, D. et al. (n.d.). THU0645 Impact of second-line therapy with abatacept versus other targeted dmards on the risk for infection-related hospitalizations and associated costs among ra patients in the united states. Annals of the rheumatic diseases. pp. 517-518. [Online].